Provided by Tiger Trade Technology Pte. Ltd.

Nasdaq

97.54
-1.0700-1.09%
Post-market: 97.700.1600+0.16%19:42 EDT
Volume:3.28M
Turnover:319.75M
Market Cap:54.52B
PE:28.44
High:98.96
Open:98.31
Low:97.04
Close:98.61
52wk High:101.79
52wk Low:76.55
Shares:559.00M
Float Shares:496.00M
Volume Ratio:1.39
T/O Rate:0.66%
Dividend:1.12
Dividend Rate:1.15%
EPS(TTM):3.43
EPS(LYR):3.09
ROE:16.52%
ROA:5.85%
PB:4.55
PE(LYR):31.57

Loading ...

Profusa Regains NASDAQ Compliance on Publicly Held Shares Requirement

Reuters
·
Aug 31

Change Agents Says Catch-up AI Platform Development Funded by AWS Grant

Reuters
·
Aug 31

Canadian Goldfields Launches 2026 Fall Exploration Program at Miminiska Gold Project in Ontario

Reuters
·
Aug 31

Daré Bioscience Wins NIH Award of About $908,000 for Preterm Birth Program DARE-PTB2

Reuters
·
Aug 31

NevGold Files NI 43-101 Technical Report for Limousine Butte Gold-Antimony Resource Estimate in Nevada

Reuters
·
Aug 31

OneMedNet Signs Deal to Supply De-Identified Clinical Data to AI Drug Developer

Reuters
·
Aug 31

American Battery Technology Hosts DOE, Nevada Officials at Reno Battery Recycling Facility Tour

Reuters
·
Aug 31

Latin Metals Partners with Geomorphic AI to Speed Argentina Project Generation

Reuters
·
Aug 31

Endovia Plans FDA Pre-Submission Conference for CannEpil Z Filing

Reuters
·
Aug 31

Lexicon Post Hoc Soloist-WHF Analysis Shows Sotagliflozin Benefit Holds Across Baseline Blood Pressure Levels

Reuters
·
Aug 31

Acrivon Therapeutics Names Michaela Levin Chief Business Officer

Reuters
·
Aug 31

Standard Lithium Signs 10-Year Lithium Offtake Deal with LG Energy Solution for 8,000 Tonnes a Year

Reuters
·
Aug 31

Allogene Therapeutics to Present at Citi Biopharma Back to School Conference

Reuters
·
Aug 31

Telos Wins $34.3 Million US Air Force Intelligence Cybersecurity Task Order

Reuters
·
Aug 31

Arch Biopartners Wins Central IRB Approval for Phase II LSALT Peptide CS-AKI Trial in US

Reuters
·
Aug 31

Alligator Bioscience Registers Prospectus for Unit Rights Issue with Free Warrants

Reuters
·
Aug 31

Amarin Highlights Reduce-it Post Hoc Study Linking Icosapent Ethyl to Lower Tissue Factor Levels, Fewer CV Events

Reuters
·
Aug 31

Xeriant Begins Commercial Production of NexBoard Construction Panel

Reuters
·
Aug 31

Chemomab CEO Adi Mor Presents at H.C. Wainwright Global Investor Conference

Reuters
·
Aug 31

BioVie Completes Treatment Phase of Phase 2 Long COVID Trial for Bezisterim

Reuters
·
Aug 31